Tandem Diabetes Care (TNDM) Other financing activities (2016 - 2024)

Tandem Diabetes Care (TNDM) has 4 years of Other financing activities data on file, last reported at $183000.0 in Q1 2024.

• For the quarter ending Q1 2024, Other financing activities changed N/A year-over-year to $183000.0; the trailing twelve-month figure through Dec 2024 stood at $183000.0 (up 357.75% YoY), and the FY2024 full-year result was $183000.0, up 357.75% from the prior year.
• Other financing activities for Q1 2024 stood at $183000.0, up from -$71000.0 in the prior quarter.
• Across five years, Other financing activities topped out at $183000.0 in Q1 2024 and bottomed at -$405000.0 in Q3 2022.
• The 3-year median for Other financing activities is $6000.0 (2022), against an average of -$52500.0.
• Peak annual rise in Other financing activities reached 82.47% in 2023, while the deepest fall reached 82.47% in 2023.
• A 3-year view of Other financing activities shows it stood at $83000.0 in 2022, then plunged by 185.54% to -$71000.0 in 2023, then soared by 357.75% to $183000.0 in 2024.
• The last three Other financing activities figures came in at $183000.0 (Q1 2024), -$71000.0 (Q3 2023), and $83000.0 (Q4 2022), per Business Quant data.

Peer Comparison